✦ LIBER ✦

Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer

✍ Scribed by Walter M. Stadler; Nicholas J. Vogelzang; Everett E. Vokes; Jane Charette; Greg Whitman

Publisher: Springer
Year: 1992
Tongue: English
Weight: 395 KB
Volume: 31
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685550

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fluorodeoxyuridine with continuous leuco

Fluorodeoxyuridine with continuous leucovorin infusion a phase ii clinical trial in patients with metastatic colorectal cancer

✍ Robert D. Levin; John H. Gordon 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

Daily alternating administration of high

Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study

✍ Lothar Bergmann; Klaus Fenchel; Eckhart Weidmann; Hans-Martin Enzinger; Bernhard 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 852 KB

Continuous infusion of high-dose 5-fluor

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II study

✍ Cornelis J. A. Punt; Jos Th. M. Burghouts; Jelle J. Croles; Peter A. van Liessum 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

A phase II study of continuous infusion

A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma

✍ Jean L. Grem; Nanette McAtee; Frank Balis; Robert Murphy; David Venzon; Barnett 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer

Phase II trial of 5-fluorouracil, interf

Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma

✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d